Diagnostics
Limited Value of Diagnostics Without Therapeutic Options
There is little to no clinical value in a diagnostic test for neurodegenerative diseases if there is no therapeutic available which might improve the diagnosis.
Clinical Relevance of IV NAD+ in Neurodegenerative Disease Treatment
With validation of IV NAD+ to treat Parkinson’s and similar neurodegenerative diseases, there is a significant opportunity for diagnostic technologies to become clinically relevant.
Licensing Breakthrough Diagnostic Technology for Early Detection
PMT is working to license one of these groundbreaking technologies which analyzes the visual cortex and can accurately identify “signatures” which uniquely indicate the presence of Parkinson’s, CTE/TBI, Alzheimer’s and Dementia ahead of progressed symptoms.
Early Diagnosis and Therapeutics to Improve Patient Care
This early diagnosis coupled with a disease modifying therapeutic can dramatically improve the standard of care for patients afflicted with various neurodegenerative diseases.
Phone
(234) 234-3467
Location
12345 Performance Med Tech St.
Richmond, VA 23173
support@performancemedtech.com